Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Lowered to $43 at Deutsche Bank

May 12, 2017 6:31 AM
Deutsche Bank lowered its price target on Teva Pharma (NYSE: TEVA) to $43.00 (from $45.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles